Permeation studies on freshly excised rat gastric mucosa: Influence of pH

Drug Development and Industrial Pharmacy

Volumn 37, Issue 5, 2011, Pages 518-525

  Leithner, Katharina ^a   Grabovac, Vjera ^a   Albrecht, Karin ^a   Hombach, Juliane ^a   Klima, Günter ^b   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

cell viability; Gastric absorption; permeability; pH dependence; Ussing chamber

Indexed keywords

BACITRACIN; CIMETIDINE; FLUORESCEIN SODIUM; PROPRANOLOL;

ACIDITY; ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; FLUORESCENCE; IN VITRO STUDY; NONHUMAN; RAT; STOMACH MUCOSA; STOMACH PH;

ANIMALS; BACITRACIN; CIMETIDINE; FLUORESCEIN; FLUORESCEIN-5-ISOTHIOCYANATE; GASTRIC MUCOSA; HYDROGEN-ION CONCENTRATION; MALE; PERMEABILITY; PHARMACOKINETICS; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79953798446     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.527348     Document Type: Article

References (31)

1. Akiyama Y, Nagahara N, Nara E, Kitano M, Iwasa S, Yamamoto I, Azuma J, Ogawa Y. (1998). Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites. J Pharm Pharmacol 50:159-166. (Pubitemid 28102572)
2. Ashley SW, Soybel DI, Moore CD, Cheung LY. (1987). Intracellular pH (pHi) in gastric surface epithelium is more susceptible to serosal than mucosal acidification. Surgery 102:371-379. (Pubitemid 17158339)
3. Bernkop-Schnürch A, Reich-Rohrwig E, Marschütz M, Schuhbauer H, Kratzel M. (2004). Development of a sustained release dosage form for alpha-lipoic acid. II. Evaluation in human volunteers. Drug Dev Ind Pharm 30:35-42. (Pubitemid 38240474)
4. Craig PN. (1990). Drug Compendium, in Cumulative Subject Index & Drug Compendium (Drayton CJ, ed), Vol. 6, pp. 237-991, Pergamon Press, Oxford.
5. Crespy V, Morand C, Besson C, Manach C, Demigne C, Remesy C. (2002). Quercetin, but not its glycosides, is absorbed from the rat stomach. J Agric Food Chem 50:618-621. (Pubitemid 34106688)
6. Da Violante G, Zerrouk N, Richard I, Provot G, Chaumeil JC, Arnaud P. (2002). Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco2/TC7 colon tumor cell cultures. Biol Pharm Bull 25:1600-1603. (Pubitemid 39663677)
7. Dahan A, Amidon GL. (2009). Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Mol Pharm 6:19-28.
8. DeSesso JM, Jacobson CF. (2001). Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats. Food Chem Toxicol 39:209-228. (Pubitemid 32244129)
9. Freshney RI. (2005). Culture of Animal Cells: A Manual of Basic Technique, 5th edition, p. 117, Wiley-Liss, New York.
10. Iqbal T, Karyekar CS, Kinjo M, Ngan GC, Dowling TC. (2004). Validation of a simplified method for determination of cimetidine in human plasma and urine by liquid chromatography with ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci 799:337-341. (Pubitemid 37510237)
11. Karlarli T. (1989). Gastrointestinal absorption of drugs. Crit Rev Ther Drug Carrier Syst 6:39-86.
12. Kimura T, Higaki K. (2002). Gastrointestinal transit and drug absorption. Biol Pharm Bull 25:149-164. (Pubitemid 39592096)
13. Kromer W, Krüger U, Huber R, Hartmann M, Steinijans VW. (1998). Differences in pH-dependent activation rates of substituted benzimidazoles and biological in vitro correlates. Pharmacology 56:57-70. (Pubitemid 28039688)
14. Kwak HH, Kim JO, Chung HK, Choi SM, Kim JH, Kwon JW, Yoo M, Lee JH, Lee MG. (2006). Pharmacokinetics of oral amlodipine orotate in vagotomized dogs. Biopharm Drug Dispos 27:141-145.
15. Luciano L, Reale E. (1992). The "limiting ridge" of the rat stomach. Arch Histol Cytol 55(Suppl):131-138.
16. Menon A, Ritschel WA, Sakr A. (1991). Biopharmaceutic evaluation of furosemide as a potential candidate for a modified release peroral dosage form. Methods Find Exp Clin Pharmacol 13:629-636.
17. Moazed B, Hiebert LM. (2009). Movement of heparins across rat gastric mucosa is dependent on molecular weight and pH. Pharm Res 26:189-195.
18. Mummaneni V, Amidon GL, Dressman JB. (1995). Gastric pH influences the appearance of double peaks in the plasma concentration-time profiles of cimetidine after oral administration in dogs. Pharm Res 12:780-786.
19. Palm K, Luthman K, Ros J, Grasjo J, Artursson P. (1999). Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. J Pharmacol Exp Ther 291:435-443. (Pubitemid 29503509)
20. Panchagnula R, Bansal T, Varma MV, Kaul CL. (2004). Reversed-phase liquid chromatography with ultraviolet detection for simultaneous quantitation of indinavir and propranolol from ex-vivo rat intestinal permeability studies. J Chromatogr B Analyt Technol Biomed Life Sci 806:277-282. (Pubitemid 38686517)
21. Passamonti S, Vrhovsek U, Vanzo A, Mattivi F. (2003). The stomach as a site for anthocyanins absorption from food. FEBS Lett 544:210-213. (Pubitemid 36628064)
22. Piskula MK, Yamakoshi J, Iwai Y. (1999). Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett 447:287-291. (Pubitemid 29146103)
23. Pretorius E, Bouic PJ. (2009). Permeation of four oral drugs through human intestinal mucosa. AAPS PharmSciTech 10:270-275.
24. Romeis B. (1968). Mikroskopische Technik, 16th edition, §304, R. Oldenburg, München, Wien.
25. Schulzke JD, Gitter AH, Mankertz J, Spiegel S, Seidler U, Amasheh S, Saitou M, Tsukita S, Fromm M. (2005). Epithelial transport and barrier function in occludin-deficient mice. Biochim Biophys Acta 1669:34-42. (Pubitemid 40544519)
26. Streubel A, Siepmann J, Bodmeier R. (2006). Gastroretentive drug delivery systems. Expert Opin Drug Deliv 3:217-233. (Pubitemid 43338093)
27. Takeuchi K, Magee D, Critchlow J, Matthews J, Silen W. (1983). Studies of the pH gradient and thickness of frog gastric mucus gel. Gastroenterology 84:331-340. (Pubitemid 13224274)
28. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. (1987). Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735-7738.
29. U.S. Pharmacopeia, 30. National Formulary 25, Vol. 1, p. 810.
30. Varma MV, Ashokraj Y, Dey CS, Panchagnula R. (2003). P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res 48:347-359. (Pubitemid 36945333)
31. Wang Y, Zuo Z, Chen X, Tomlinson B, Chow MS. (2010). Improving sublingual delivery of weak base compounds using pH(max) concept: application to propranolol. Eur J Pharm Sci 39: 272-278.